Outset Medical (OM) Restructuring Costs (2024)
Outset Medical (OM) reported Restructuring Costs of $1.5 million for Q4 2024, up 7.14% on a QoQ basis from $1.4 million in Q3 2024.
Outset Medical (OM) has 1 years of Restructuring Costs data on file, last reported at $1.5 million in Q4 2024.
- Quarterly Restructuring Costs changed N/A year-over-year to $1.5 million in Q4 2024, while the trailing twelve-month figure through Dec 2024 was $5.6 million (changed N/A YoY) and the FY2024 annual result came in at $1.5 million, down 40.0% from the prior year.
- Restructuring Costs climbed to $1.5 million in Q4 2024 per OM's latest filing, from $1.4 million in the prior quarter.
- Across five years, Restructuring Costs topped out at $2.7 million in Q1 2024 and bottomed at $1.4 million in Q3 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Outset Medical | 90,946.35 | -286.55 Mn | 12.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 1.50 Mn |
| Sep 30, 2024 | 1.40 Mn |
| Mar 31, 2024 | 2.70 Mn |